“…However, this gap is closing with the recent accumulation of studies in both species, including the improved understanding of the similarities and differences in pluripotency ( Brons et al, 2007 ; Tesar et al, 2007 ; Weinberger et al, 2016 ), methods to culture blastocysts towards the post-implantation stage in vitro ( Bedzhov et al, 2014 ; Deglincerti et al, 2016 ; Shahbazi et al, 2016 ), advanced single cell omics studies to demarcate cell identities and regulatory networks that underlie EPI, PrE/HYPO and TE specification ( Nakamura et al, 2015 ; Nakamura et al, 2016 ; Meistermann et al, 2021 ), and the in vitro differentiation of TE and its derivatives ( Castel et al, 2020 ; Io et al, 2021 ). Through the use of human extended pluripotent/expanded potential stem cells (EPSCs), induced pluripotent stem cells (iPSCs) and naïve ESCs, several groups have reported their first successes with human blastoid generation ( Fan et al, 2021 ; Kagawa et al, 2021 ; Liu et al, 2021 ; Sozen et al, 2021 ; Yanagida et al, 2021 ; Yu et al, 2021 ). The methods employed have yet some marked differences between the groups, underlining the different angles and controversies surrounding the cellular subtypes and signaling pathways involved in early human development.…”